Itrungar (Itraconazole)


Treatment of mycoses, caused by itraconazole-susceptible agents in patients without immune system disorders:
- gynaecological diseases: vulvovaginal candidiasis;
- dermatological diseases: dermatomycosis, pityriasis versicolor; 
- ophthalmological diseases: mycotic keratitis;
- oral candidiasis;
- onychomycoses, caused by dermatophytes, yeast, molds;
- systemic mycoses: systemic aspergillosis or candidiasis, cryptococcosis (including cryptococcal meningitis): patients with immune system disorders and all patients with cryptococcosis of the central nervous system the preparation is indicated only in case of ineffectiveness of the therapy with other atimycotic preparations;
- histoplasmosis, sporotrichosis, paracoccidioidomycosis, blastomycosis and other systemic mycoses, which occur very seldom, or tropical mycoses.

Open instruction


This section is intended only for health specialists.

If you are not a specialist in the field of health (physician, pharmacist or health expert), you are not recommended to visit this section.

Confirming that you are an expert in the field of health, you agree to all the following conditions of this section:

  •  This section includes all sorts of scientific and other information in the field of medicine and health;
  •  This section is intended to acquaint the specialists with new researches and programs in the field of medicine and health;
  •  This section is also intended for communication and exchange of professional experience and knowledge by health specialists.
  •  The information contained in this section is presented only for information, it is not an advertising, and cannot be considered as instructions for use;
  •  References of medicinal preparations presented in this section are for information only. The information contains the official instructions for medical use of medical products.

By clicking OK, you confirm that you are a specialist in the field of health